IRIS
RINALDI, Luca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 12.145
NA - Nord America 5.638
AS - Asia 5.372
SA - Sud America 935
Continente sconosciuto - Info sul continente non disponibili 467
AF - Africa 65
OC - Oceania 5
Totale 24.627
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 8.638
US - Stati Uniti d'America 5.486
SG - Singapore 1.802
IE - Irlanda 1.108
CN - Cina 993
IT - Italia 927
VN - Vietnam 881
HK - Hong Kong 829
BR - Brasile 767
GB - Regno Unito 397
DE - Germania 323
KR - Corea 290
UA - Ucraina 174
IN - India 163
FR - Francia 120
JP - Giappone 110
GR - Grecia 83
FI - Finlandia 72
CA - Canada 70
NL - Olanda 63
TR - Turchia 55
AR - Argentina 53
MX - Messico 46
SE - Svezia 45
BD - Bangladesh 43
EC - Ecuador 29
ID - Indonesia 29
PL - Polonia 27
ES - Italia 26
RO - Romania 26
CO - Colombia 25
AT - Austria 23
PK - Pakistan 23
BE - Belgio 22
CZ - Repubblica Ceca 18
IQ - Iraq 18
ZA - Sudafrica 18
EG - Egitto 16
VE - Venezuela 16
IR - Iran 14
LT - Lituania 14
CL - Cile 11
PE - Perù 11
AZ - Azerbaigian 10
AE - Emirati Arabi Uniti 9
CR - Costa Rica 9
PH - Filippine 9
PY - Paraguay 9
SA - Arabia Saudita 9
TW - Taiwan 9
UZ - Uzbekistan 9
MA - Marocco 8
MY - Malesia 8
PT - Portogallo 8
CH - Svizzera 7
JM - Giamaica 7
UY - Uruguay 7
BO - Bolivia 6
KZ - Kazakistan 6
NP - Nepal 6
OM - Oman 6
TN - Tunisia 6
AU - Australia 5
IL - Israele 5
JO - Giordania 5
KG - Kirghizistan 5
HN - Honduras 4
KE - Kenya 4
LB - Libano 4
TH - Thailandia 4
TT - Trinidad e Tobago 4
BB - Barbados 3
CY - Cipro 3
DK - Danimarca 3
ET - Etiopia 3
EU - Europa 3
MK - Macedonia 3
RS - Serbia 3
AM - Armenia 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
GE - Georgia 2
HR - Croazia 2
HU - Ungheria 2
LA - Repubblica Popolare Democratica del Laos 2
MO - Macao, regione amministrativa speciale della Cina 2
PA - Panama 2
PR - Porto Rico 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
TJ - Tagikistan 2
UG - Uganda 2
AL - Albania 1
AN - Antille olandesi 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BW - Botswana 1
DM - Dominica 1
Totale 24.149
Salva come PNG Salva come JPEG
Città #
Moscow 3.025
Dublin 1.096
San Jose 847
Singapore 816
Hong Kong 808
Santa Clara 650
Chandler 399
Ashburn 334
Ho Chi Minh City 293
Jacksonville 293
Seoul 283
Hanoi 218
The Dalles 193
New York 183
Naples 163
Hefei 161
Princeton 153
Roxbury 148
Beijing 137
Dallas 111
Bremen 98
Bengaluru 93
Los Angeles 90
Caserta 83
Cambridge 82
São Paulo 76
Medford 73
Munich 64
Da Nang 62
Ann Arbor 58
Wilmington 51
Des Moines 49
Memphis 44
Orem 43
Haiphong 42
Chicago 39
Amsterdam 37
Atlanta 36
Falkenstein 36
Milan 36
Boardman 30
Frankfurt am Main 29
Napoli 29
Nanjing 28
Council Bluffs 27
Redwood City 25
Woodbridge 25
Helsinki 24
London 24
Brussels 21
Nuremberg 21
Washington 21
Chennai 20
Jinan 20
Brooklyn 18
Montreal 18
Mountain View 18
Phoenix 18
Warsaw 18
Hải Dương 17
Aversa 16
Belo Horizonte 16
Houston 16
Tokyo 16
Denver 15
Rio de Janeiro 15
Rome 15
Brasília 14
Hillsboro 14
Shenyang 14
Tianjin 14
Toronto 14
Turku 14
Buffalo 13
Florence 13
Guayaquil 13
Salvador 13
Shanghai 13
Curitiba 12
Lahore 12
Mexico City 12
Porto Alegre 12
Salerno 12
Seattle 12
Giugliano In Campania 11
Manchester 11
Nha Trang 11
Norwalk 11
Stockholm 11
Thái Nguyên 11
Biên Hòa 10
Boston 10
Changsha 10
Dhaka 10
Hangzhou 10
Monserrato 10
Shenzhen 10
Vienna 10
Avellino 9
Istanbul 9
Totale 12.448
Salva come PNG Salva come JPEG
Nome #
Adiponectin and insulin resistance are related to restenosis and overall new PCI in subjects with normal glucose tolerance: the prospective AIRE Study 223
Helicobacter pylori and skin disorders: a comprehensive review of the available literature 219
Pulsed laser ablation of magnetic nanoparticles as a novel antibacterial strategy against gram positive bacteria 210
Application and internal validation of lung ultrasound score in COVID-19 setting: The ECOVITA observational study 202
What changed in the Italian internal medicine and geriatric wards during the lockdown 198
Cardiac Hypertrophy: from Pathophysiological Mechanisms to Heart Failure Development 197
A genic and epigenetic combination therapy for liver cancer 194
Bartter syndrome 191
Mechanisms and clinical behavior of hepatocellular carcinoma in HBV and HCV infection and alcoholic and non-alcoholic fatty liver disease 191
Association between Renal Function at Admission and COVID-19 in-Hospital Mortality in Southern Italy: Findings from the Prospective Multicenter Italian COVOCA Study 185
Non-invasive respiratory support in SARS-CoV-2 related acute respiratory distress syndrome: when is it most appropriate to start treatment? 183
Hepatocellular carcinoma in chronic HBV-HCV co-infection is correlated to fibrosis and disease duration 175
A Controversial Case of a Double Hepatic Incidentaloma in a Male Patient with Kidney Failure 168
Renal phenotype in bardet-biedl syndrome: A combined defect of urinary concentration and dilution is associated with defective urinary aqp2 and umod excretion 167
Predictors of in-hospital mortality of COVID-19 patients and the role of telemetry in an internal medicine ward during the third phase of the pandemic 167
Chronic HCV infection and neurological and psychiatric disorders: an overview. 165
Genetic characterization of Italian patients with Bardet-Biedl syndrome and correlation to ocular, renal and audio-vestibular phenotype: Identification of eleven novel pathogenic sequence variants 165
Cardiorenal Impact of SGLT-2 Inhibitors: A Conceptual Revolution in The Management of Type 2 Diabetes, Heart Failure and Chronic Kidney Disease 165
COVID-19 and arrhythmia: The factors associated and the role of myocardial electrical impulse propagation. An observational study based on cardiac telemetric monitoring 164
IMPACT OF TYPE II DIABETES ON HCC APPEARANCE IN PATIENTS TREATED WITH DIRECT ACTING ANTIVIRALS 164
Sonoporation by microbubbles as gene therapy approach against liver cancer 161
Features of microvessel density (MVD) and angiogenesis inhibitors in therapeutic approach of hepatocellular carcinoma (HCC) 161
Effects of a Combination of Empagliflozin Plus Metformin vs. Metformin Monotherapy on NAFLD Progression in Type 2 Diabetes: The IMAGIN Pilot Study 160
ULTRASOUND TIPS IN THE LUNG CANCER DIAGNOSIS: A PILOT STUDY 160
Eighteen-month lamivudine prophylaxis on preventing occult hepatitis B virus infection reactivation in patients with haematological malignancies receiving immunosuppression therapy 160
HBV Infection and Host Interactions: The Role in Viral Persistence and Oncogenesis 159
Epstein Barr virus infection reactivation as a possible trigger of primary biliary cirrhosis-like syndrome in a patient with multiple sclerosis in the course of fingolimod treatment. 158
Predictors of early and late hepatocellular carcinoma recurrence 156
Boceprevir or telaprevir in hepatitis C virus chronic infection: The Italian real life experience. 155
Dysregulated Epicardial Adipose Tissue as a Risk Factor and Potential Therapeutic Target of Heart Failure with Preserved Ejection Fraction in Diabetes 155
Mortality and risk factors of vaccinated and unvaccinated COVID-19 frail patients treated with anti-SARS-CoV-2 monoclonal antibodies. A real-world study 154
Aspirin in a Diabetic Retinopathy Setting: insights from NO BLIND Study 154
Metabolic dysfunction-associated steatotic liver disease (MASLD): a systemic disease with a variable natural history and challenging management 153
Efficacy and safety of the sofosbuvir/velpatasvir combination for the treatment of patients with early mild to moderate COVID-19 153
Current Knowledge on the Pathophysiology of Lean/Normal-Weight Type 2 Diabetes 152
Peripheral Neuropathy in Diabetes Mellitus: Pathogenetic Mechanisms and Diagnostic Options 152
Atherosclerosis and chronic hepatitis C virus (HCV) infection: Role of liver steatosis 152
Factors affecting long-term changes of liver stiffness in direct-acting anti-hepatitis C virus therapy: a multicenter prospective study 152
Coronary Microvascular Dysfunction in Diabetes Mellitus: Pathogenetic Mechanisms and Potential Therapeutic Options 151
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry 150
Remdesivir plus dexamethasone versus dexamethasone alone for the treatment of COVID-19 patients requiring supplemental O2 therapy: a prospective controlled non-randomized study 150
Chronic hepatitis C virus infection and neurological and psychiatric disorders: an overview. 149
Tenofovir disoproxil fumarate monotherapy maintains HBV suppression achieved by a "de novo" combination of lamivudine-adefovir: a pilot study 149
Diagnostic performance of LI-RADS in adult patients with rare hepatic tumors 148
[Next Generation Sequencing and ADPKD] 147
GLP-1 Receptor Agonists in Non-Alcoholic Fatty Liver Disease: Current Evidence and Future Perspectives 146
Can Metformin Exert as an Active Drug on Endothelial Dysfunction in Diabetic Subjects? 146
Spirometry in elderly laryngectomized patients: A feasibility study 143
Chronic Hepatitis C Virus Infection and Depression. 143
[Inhibitors of intra-cystic secretion: novel therapies in ADPKD (Autosomal Dominant Polycystic Kidney Disease)] 142
Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry 142
Neoadjuvant and Adjuvant Systemic Therapies in Loco-Regional Treatments for Hepatocellular Carcinoma: Are We at the Dawn of a New Era? 141
Clinical application of lung ultrasound score on COVID-19 setting: a regional experience in Southern Italy 141
Lack of effect on in-hospital mortality of drugs used during COVID-19 pandemic: Findings of the retrospective multicenter COVOCA study 140
Long-Term Prognosis among COVID-19 Patients: The Predictive Role Played by Hyperinflammation and Arrhythmic Disorders in Fatal Outcome 140
Editorial – Role of Highly Active Antiretroviral Therapy (HAART) for the COVID-19 treatment 140
Efficacy of Unsupervised Self-Collected Mid-Turbinate FLOQSwabs for the Diagnosis of Coronavirus Disease 2019 (COVID-19) 138
ITPase activity modulates the severity of anaemia in HCV-related cirrhosis treated with ribavirin-containing interferon-free regimens. 138
Hepatic steatosis and necro-inflammatory activity overestimated liver stiffness by transient elastography in staging liver fibrosis in chronic hepatitis C 136
Gender Differences in the Pathogenesis and Risk Factors of Hepatocellular Carcinoma 135
Impact of Acute Kidney Injury on the COVID-19 In-Hospital Mortality in Octogenarian Patients: Insights from the COVOCA Study 135
HCC and molecular targeting therapies: Back to the future 135
Liver Involvement in Patients With Systemic Sclerosis: Role of Transient Elastography in the Assessment of Hepatic Fibrosis and Steatosis 134
Cardiovascular benefits from gliflozins: Effects on endothelial function 134
Impact of chronic liver disease on SARS-CoV-2 infection outcomes: Roles of stage, etiology and vaccination 133
CURRENT HEPATOCELLULAR CARCINOMA SYSTEMIC PHARMACOLOGICAL TREATMENT OPTIONS 133
Metabolic and renal changes in patients with chronic hepatitis C infection after hepatitis C virus clearance by direct‐acting antivirals 133
GLP-1 Receptor Agonists Are Associated with Reduced Ascending Aorta Dilatation in Patients with Type 2 Diabetes: A Prospective Study 132
Impact of gliflozins on cardiac remodeling in patients with type 2 diabetes mellitus & reduced ejection fraction heart failure: A pilot prospective study. GLISCAR study 131
Ruolo patogenetico dell'adiponectina nella steatosi associata ad epatite C 131
No effect of MTP polymorphisms on PNPLA3 in HCV-correlated steatosis 131
Impact of liver fibrosis on COVID-19 in-hospital mortality in Southern Italy 131
La epatite cronica da HCV con steatosi si associa ad elevato rischio aterosclerotico. 129
Oncolytic viruses in combination therapeutic approaches with epigenetic modulators: Past, present, and future perspectives 128
Comment on: Warfarin adherence and anticoagulation control in atrial fibrillation patients-a systematic review 128
Alcohol Consumption and Liver Metabolism in the Era of MASLD: Integrating Nutritional and Pathophysiological Insights 127
Hepatic steatosis and insulin resistance are associated with serum imbalance of adiponectin/tumour necrosis factor-alpha in chronic hepatitis C patients 127
HCV-related steatosis and risk of atherosclerosis 127
Liver Involvement during SARS-CoV-2 Infection Is Associated with a Worse Respiratory Outcome in COVID-19 Patients 126
Antibiotic use and associated factors in a large sample of hospitalised older people 126
Sex-difference of multifactorial intervention on cardiovascular and mortality risk in DKD: post-hoc analysis of a randomised clinical trial 125
Circulating Vitamin D Level and Its Impact on Mortality and Recurrence in Stage III Colorectal Cancer Patients: A Systematic Review and Meta-Analysis 125
The number of risk factors not at target is associated with cardiovascular risk in a type 2 diabetic population with albuminuria in primary cardiovascular prevention. Post-hoc analysis of the NID-2 trial 125
Changes in clinical scenarios, management, and perspectives of patients with chronic hepatitis C after viral clearance by direct-acting antivirals 125
Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations. 124
Association between the spread of COVID-19 and weather-climatic parameters 124
Pathophysiological mechanisms and clinical evidence of relationship between Nonalcoholic fatty liver disease (NAFLD) and cardiovascular disease 124
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 123
Effects of combination therapy with SGLT2 inhibitors and GLP-1 receptor agonists on CRT response and clinical outcomes in in type 2 diabetes mellitus patients receiving chronic anti-diabetic medications: A multicenter observational study 122
Effects of Metformin in Heart Failure: From Pathophysiological Rationale to Clinical Evidence 120
Oxidative Stress in Type 2 Diabetes: Impacts from Pathogenesis to Lifestyle Modifications 120
Diabetic Gastroparesis: Navigating Pathophysiology and Nutritional Interventions 119
Patho-physiology of renal dysfunction in Bardet-Biedl Syndrome 119
Ruolo patogenetico dell’adiponectina nella steatosi associata ad epatite C 118
Non-alcoholic Fatty Liver Disease (NAFLD), Type 2 Diabetes, and Non-viral Hepatocarcinoma: Pathophysiological Mechanisms and New Therapeutic Strategies 117
Renal handling of uric acid 117
NAFLD and NASH in HCV Infection: Prevalence and Significance in Hepatic and Extrahepatic Manifestations. 117
Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosis. 117
Impact of chronic liver disease upon admission on COVID-19 in-hospital mortality: Findings from COVOCA study 117
Impact of direct acting antivirals (DAAs) on cardiovascular events in HCV cohort with pre-diabetes 117
Totale 14.681
Salva come PNG Salva come JPEG
Categoria #
all - tutte 87.351
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 87.351
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022939 0 4 16 27 297 20 15 23 71 64 84 318
2022/20231.940 179 61 55 86 238 121 6 98 993 21 35 47
2023/20241.111 84 30 55 64 306 169 36 38 21 40 92 176
2024/20253.362 29 65 18 59 524 396 479 308 513 399 319 253
2025/202615.011 622 713 710 668 1.287 7.981 955 594 717 321 280 163
2026/2027466 293 173 0 0 0 0 0 0 0 0 0 0
Totale 24.627